Not applicableActive Not RecruitingNCT07501793What this trial is testingDemographic Characteristics of TAK-003 Dengue Vaccine Recipients in VietnamWho this might be right forDengue Tam Anh Research Institute 800,000
Testing effectiveness (Phase 2)Study completedNCT01511250What this trial is testingStudy to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 YearsWho this might be right forHealthy Takeda 360
Early research (Phase 1)Study completedNCT00919178What this trial is testingSafety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue VirusWho this might be right forDengue Shock SyndromeDengue Hemorrhagic Fever National Institute of Allergy and Infectious Diseases (NIAID) 70
Early research (Phase 1)Study completedNCT02809443What this trial is testingGLS-5700 in Dengue Virus-Naïve AdultsWho this might be right forHealthy GeneOne Life Science, Inc. 40
Early research (Phase 1)Study completedNCT00920517What this trial is testingSafety and Immune Response to Two Doses of rDEN2/4delta30 Dengue VaccineWho this might be right forDengue Fever National Institute of Allergy and Infectious Diseases (NIAID) 25
Not applicableStudy completedNCT04023708What this trial is testingObservational Study to Evaluate the Safety of CYD Tetravalent Dengue Vaccine (CYD-TDV) in Pregnant Women and Their Offsprings Inadvertently Exposed During PregnancyWho this might be right forDengue Virus Infection Sanofi Pasteur, a Sanofi Company 104
Not applicableActive Not RecruitingNCT06388785What this trial is testingMonitor the Adverse Events of QDENGA Vaccine in Participants in MalaysiaWho this might be right forDengue Fever Takeda 2,000
Testing effectiveness (Phase 2)Study completedNCT02421367What this trial is testingStudy of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US AdultsWho this might be right forDengue U.S. Army Medical Research and Development Command 140
Early research (Phase 1)Study completedNCT02186626What this trial is testingEvaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of AgeWho this might be right forWest Nile Virus National Institute of Allergy and Infectious Diseases (NIAID) 28
Not applicableStudy completedNCT01983553What this trial is testingLong-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy StudyWho this might be right forDengueDengue FeverDengue Hemorrhagic Fever Sanofi Pasteur, a Sanofi Company 3,203
Testing effectiveness (Phase 2)Study completedNCT02741128What this trial is testingSafety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive AdultsWho this might be right forDengue FeverDengue Hemorrhagic FeverHuman Immunodeficiency Virus Sanofi Pasteur, a Sanofi Company 133
Not applicableActive Not RecruitingNCT07759596What this trial is testingBridging Economics and Public Trust: A Study of Dengue Vaccine Cost-effectiveness and Acceptance in Thais Visiting HospitalWho this might be right forDengue Fever Mahidol University 350
Testing effectiveness (Phase 2)UnknownNCT01696422What this trial is testingPhase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) VaccineWho this might be right forDengue Butantan Institute 300
Testing effectiveness (Phase 2)Study completedNCT00370682What this trial is testingA Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in ThailandWho this might be right forDengue U.S. Army Medical Research and Development Command 120
Not applicableActive Not RecruitingNCT07812142What this trial is testingRetrospective Analysis of the Second Year of Safety Surveillance of the Qdenga® (TAK-003) Vaccine in Private Vaccination Centers, Including a Sub-analysis of Safety in Adults Over 60 Years of AgeWho this might be right forDengue Vaccines Fundación Vacunar 94,526
Early research (Phase 1)Study completedNCT04935801What this trial is testingA Phase-I Study of a Nanoparticle-based Peptide Vaccine Against Dengue VirusWho this might be right forDengue Gylden Pharma Ltd 26
Testing effectiveness (Phase 2)Study completedNCT00730288What this trial is testingStudy of ChimeriVax™ Dengue Tetravalent Vaccine in Adult SubjectsWho this might be right forDengueDengue FeverDengue Hemorrhagic Fever+1 more Sanofi 35
Not applicableLooking for participantsNCT06843226What this trial is testingA Study in Children and Teenagers to Learn if a TDV Dengue Vaccination Lowers the Chance of Hospital Stays for DengueWho this might be right forDengue Fever Takeda 70,000
Large-scale testing (Phase 3)Ended earlyNCT02992418What this trial is testingStudy of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy SubjectsWho this might be right forDengue FeverDengue Hemorrhagic Fever Sanofi Pasteur, a Sanofi Company 688
Early research (Phase 1)Study completedNCT01702857What this trial is testingA Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)Who this might be right forDengue Fever U.S. Army Medical Research and Development Command 100